
Nested Therapeutics
Nested Therapeutics: A biotech innovator designing impactful therapeutics through creative service.

Nested Therapeutics: A biotech innovator designing impactful therapeutics through creative service.
Nested Therapeutics, a biotech company, is dedicated to advancing precision oncology medicine. Founded with a mission to inspire service and drive impactful innovation, the company focuses on identifying new driver mutations to develop therapeutics that offer a perfect fit for overlooked opportunities. Their vision is to push the boundaries of precision medicine to reach a broader group of patients, particularly in the field of oncology. Nested Therapeutics offers a pipeline of innovative therapeutic solutions designed to address unmet medical needs.
The company has attracted notable investors and industry experts who share its vision for transformative healthcare solutions. Among its key achievements, Nested Therapeutics has made significant strides in identifying novel driver mutations and developing corresponding therapies, positioning itself as a leader in precision oncology. The overall impact of Nested Therapeutics lies in its commitment to expanding the reach of precision medicine, ultimately aiming to improve patient outcomes and revolutionize cancer treatment.
Companies similar to Nested Therapeutics include Alterome Therapeutics, Synnovation Therapeutics, Odyssey Therapeutics and Alphina Therapeutics.
Nested Therapeutics was founded in 2021.
Nested Therapeutics' headquarters is located in Cambridge, MA, US.
Nested Therapeutics' most recent funding round was for $90M (USD) in October 2022.
As of Oct 6, 2022, Nested Therapeutics has disclosed funding of $125M (USD). Undisclosed round amounts are excluded.
Nested Therapeutics has 50 employees as of Feb 4, 2024.

Alphina Therapeutics
alphinatx.com